心电图检测与14天心脏监测检测的心房颤动在卒中复发风险上的差异
该回顾性、基于登记的队列研究纳入2018至2020年伦敦安大略卒中登记中连续缺血性卒中及短暂性脑缺血发作(TIA)患者,比较心电图检测的心房颤动(AF)与经14天动态心电图(PCM)检测的AF对复发性缺血性卒中的风险差异。结果显示,心电图检测的AF组复发缺血性卒中风险显著高于PCM检测的AF组(调整后风险比5.06,95%CI 1.13-22.7;P=0.034)。
要点
- 心电图检测的AF患者复发缺血性卒中风险是PCM检测AF患者的5.06倍(调整后HR 5.06,95%CI 1.13-22.7)。
- PCM检测的AF中位持续时间为5.2小时,AF负荷中位数为2.23%。
- 随访结束时或首次事件时抗凝治疗率为83.1%。
核心结论
- 在抗凝治疗率>80%的缺血性卒中及TIA队列中,心电图检测的AF与PCM检测的AF相比,调整后复发性缺血性卒中风险高约5倍。
研究设计与样本
- 回顾性、基于登记的队列研究,纳入2018至2020年伦敦安大略卒中登记中连续的缺血性卒中及TIA患者,心电图检测的AF和PCM检测的AF均要求持续时间≥30秒。
- 共纳入366例患者,中心电图检测的AF 218例,PCM检测的AF 148例;中位PCM监测时间为12天(四分位距8.8-14.0天)。
主要发现
- PCM检测的AF中位持续时间为5.2小时(四分位距0.3-33.0小时),AF负荷中位数为2.23%(四分位距0.13%-12.25%)。
- 随访结束时或首次事件时抗凝治疗率为83.1%。
- 中位随访17个月(四分位距5-34个月)后,心电图检测的AF组有16例发生复发性缺血性卒中(其中13例使用抗凝药),PCM检测的AF组有2例发生复发性缺血性卒中(均使用抗凝药)。
- 心电图检测的AF组和PCM检测的AF组的复发性缺血性卒中发生率分别为4.05例/100患者年和0.72例/100患者年,调整后风险比5.06(95%CI 1.13-22.7;P=0.034)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemic stroke and transient ischemic attack (TIA) standard-of-care etiological investigations include an ECG and prolonged cardiac monitoring (PCM). Atrial fibrillation (AF) detected after stroke has been generally considered a single entity, regardless of how it is diagnosed. We hypothesized that ECG-detected AF is associated with a higher risk of stroke recurrence than AF detected on 14-day Holter (PCM-detected AF). METHODS: We conducted a retrospective, registry-based, cohort study of consecutive patients with ischemic stroke and TIA included in the London Ontario Stroke Registry between 2018 and 2020, with ECG-detected and PCM-detected AF lasting ≥30 seconds. We quantified PCM-detected AF burden. The primary outcome was recurrent ischemic stroke, ascertained by systematically reviewing all medical records until November 2022. We applied marginal cause-specific Cox proportional hazards models adjusted for qualifying event type (ischemic stroke versus TIA), CHA₂DS₂-VASc score, anticoagulation, left ventricular ejection fraction, left atrial size, and high-sensitivity troponin T to estimate adjusted hazard ratios for recurrent ischemic stroke. RESULTS: We included 366 patients with ischemic stroke and TIA with AF, 218 ECG-detected, and 148 PCM-detected. Median PCM duration was 12 (interquartile range, 8.8-14.0) days. Median PCM-detected AF duration was 5.2 (interquartile range, 0.3-33.0) hours, with a burden (total AF duration/total net monitoring duration) of 2.23% (interquartile range, 0.13%-12.25%). Anticoagulation rate at the end of follow-up or at the first event was 83.1%. After a median follow-up of 17 (interquartile range, 5-34) months, recurrent ischemic strokes occurred in 16 patients with ECG-detected AF (13 on anticoagulants) and 2 with PCM-detected AF (both on anticoagulants). Recurrent ischemic stroke rates for ECG-detected and PCM-detected AF groups were 4.05 and 0.72 per 100 patient-years (adjusted hazard ratio, 5.06 [95% CI, 1.13-22.7]; P=0.034). CONCLUSIONS: ECG-detected AF was associated with 5-fold higher adjusted recurrent ischemic stroke risk than PCM-detected AF in a cohort of ischemic stroke and TIA with >80% anticoagulation rate.
引用
- Alvarado-Bolaños A, Ayan D, Khaw AV, et al. Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring. Stroke. 2023. PMID: 37377007. doi:10.1161/STROKEAHA.123.043672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。